GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Return-on-Tangible-Equity

Invitro International (Invitro International) Return-on-Tangible-Equity : -74.96% (As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Invitro International's annualized net income for the quarter that ended in Jun. 2097 was $-0.79 Mil. Invitro International's average shareholder tangible equity for the quarter that ended in Jun. 2097 was $1.06 Mil. Therefore, Invitro International's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2097 was -74.96%.

The historical rank and industry rank for Invitro International's Return-on-Tangible-Equity or its related term are showing as below:

IVRO's Return-on-Tangible-Equity is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -1.945
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Invitro International Return-on-Tangible-Equity Historical Data

The historical data trend for Invitro International's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International Return-on-Tangible-Equity Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
Return-on-Tangible-Equity
Get a 7-Day Free Trial -680.00 -127.59 -86.27 -66.67 -77.55

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -64.95 -101.33 -95.24 -136.80 -74.96

Competitive Comparison of Invitro International's Return-on-Tangible-Equity

For the Diagnostics & Research subindustry, Invitro International's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invitro International's Return-on-Tangible-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Invitro International's Return-on-Tangible-Equity falls into.



Invitro International Return-on-Tangible-Equity Calculation

Invitro International's annualized Return-on-Tangible-Equity for the fiscal year that ended in Sep. 2096 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Sep. 2096 )  (A: Sep. 2095 )(A: Sep. 2096 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Sep. 2096 )  (A: Sep. 2095 )(A: Sep. 2096 )
=-1.9/( (2.8+2.1 )/ 2 )
=-1.9/2.45
=-77.55 %

Invitro International's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2097 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Jun. 2097 )  (Q: Mar. 2097 )(Q: Jun. 2097 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Jun. 2097 )  (Q: Mar. 2097 )(Q: Jun. 2097 )
=-0.792/( (1.155+0.958)/ 2 )
=-0.792/1.0565
=-74.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2097) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Invitro International  (OTCPK:IVRO) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Invitro International Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Invitro International's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Invitro International (Invitro International) Business Description

Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.